Nothing. What has changed is the ridiculous over-reaction to Hillary Clinton's comment about controlling drug costs. She's might not even be the nominee, let alone POTUS, and unlikely to get Congress to put a dent in big pharma even if she is elected. Investors who sell a great stock like this on such campaign b.s. are nothing more than a flock of cared sheep who dash off a cliff at the sound of a car horn.